Clinical Trial Update: Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation [NA]

View source ↗

Summary

This clinical trial update notes recruitment for an adjuvant PD-1 inhibitor in patients with early-stage hepatocellular carcinoma after microwave ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 inhibitor (adjuvant)

Snippet

Sponsor: Chen Xiaoping | Conditions: Hepatocellular Carcinoma | NA | Status: RECRUITING